Manchester Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52 | Hold |
3
| – | – | ﹤0.01% | 1194 |
|
|
2025
Q1 | $66 | Hold |
3
| – | – | ﹤0.01% | 1162 |
|
|
2024
Q4 | $96 | Hold |
3
| – | – | ﹤0.01% | 1144 |
|
|
2024
Q3 | $87 | Hold |
3
| – | – | ﹤0.01% | 1165 |
|
|
2024
Q2 | $116 | Hold |
3
| – | – | ﹤0.01% | 1133 |
|
|
2024
Q1 | $177 | Hold |
3
| – | – | ﹤0.01% | 1005 |
|
|
2023
Q4 | $180 | Buy |
3
+1
| +50% | +$60 | ﹤0.01% | 976 |
|
|
2023
Q3 | $77 | Hold |
2
| – | – | ﹤0.01% | 1005 |
|
|
2023
Q2 | $183 | Buy |
+2
| New | +$183 | ﹤0.01% | 935 |
|